IOM committee members respond to Endocrine Society vitamin D guideline.

Abstract

In early 2011, a committee convened by the Institute of Medicine issued a report on the Dietary Reference Intakes for calcium and vitamin D. The Endocrine Society Task Force in July 2011 published a guideline for the evaluation, treatment, and prevention of vitamin D deficiency. Although these reports are intended for different purposes, the disagreements concerning the nature of the available data and the resulting conclusions have caused confusion for clinicians, researchers, and the public. In this commentary, members of the Institute of Medicine committee respond to aspects of The Endocrine Society guideline that are not well supported and in need of reconsideration. These concerns focus on target serum 25-hydroxyvitamin D levels, the definition of vitamin D deficiency, and the question of who constitutes a population at risk vs. the general population.

DOI: 10.1210/jc.2011-2218

3 Figures and Tables

0200400600201220132014201520162017
Citations per Year

1,874 Citations

Semantic Scholar estimates that this publication has 1,874 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Rosen2012IOMCM, title={IOM committee members respond to Endocrine Society vitamin D guideline.}, author={Clifford J. Rosen and Steven A Abrams and John Aloia and Patsy M. Brannon and Steven K. Clinton and R Durazo-arvizu and John Christopher Gallagher and Richard L Gallo and Glenville Jones and Christopher S Kovacs and Joann E. Manson and Susan Taylor Mayne and A Catharine Ross and Sue A Shapses and Christine L Taylor}, journal={The Journal of clinical endocrinology and metabolism}, year={2012}, volume={97 4}, pages={1146-52} }